Nuclear survivin as a biomarker for non-small-cell lung cancer

被引：0
|
作者：
B Lu
A Gonzalez
P P Massion
Y Shyr
B Shaktour
D P Carbone
D E Hallahan
机构：
[1] Vanderbilt Ingram,Department of Radiation Oncology
[2] Cancer Center,Department of Pathology
[3] Vanderbilt University School of Medicine,Department of Medicine
[4] Vanderbilt Ingram,Department of Preventive Medicine
[5] Cancer Center,undefined
[6] Vanderbilt University School of Medicine,undefined
[7] Vanderbilt Ingram,undefined
[8] Cancer Center,undefined
[9] Vanderbilt University School of Medicine,undefined
[10] Vanderbilt Ingram,undefined
[11] Cancer Center,undefined
[12] Vanderbilt University School of Medicine,undefined
来源：
British Journal of Cancer | 2004年 / 91卷
关键词：
survivin; lung cancer; nucleus; tissue array; mitosis; apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Survivin inhibits apoptosis and promotes mitosis. We determined whether nuclear or cytoplasmic localisation of survivin predicts survival of 48 patients with resected non-small-cell lung cancer (NSCLC). Patients with nuclear staining of survivin had significantly worse survival (relative risk: 3.9, P=0.02). Therefore, survivin may be a biomarker for NSCLC.
引用
收藏
页码：537 / 540
页数：3
相关论文
共 50 条
  • [21] Molecular pathology of non-small-cell lung cancer
    Breuer, RHJ
    Postmus, PE
    Smit, EF
    RESPIRATION, 2005, 72 (03) : 313 - 330
  • [22] Anthropometric measurements in non-small-cell lung cancer
    Domenico Ferrigno
    Supportive Care in Cancer, 2002, 10 : 440 - 440
  • [23] Vaccination therapy for non-small-cell lung cancer
    Cuppens, Kristof
    Vansteenkiste, Johan
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (02) : 165 - 170
  • [24] CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis
    Peng Xu
    Xiao-Lan Xu
    Qiang Huang
    Zhi-Hong Zhang
    Yan-Bei Zhang
    Medical Oncology, 2012, 29 : 1643 - 1647
  • [25] Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo
    Zhang, Kejian
    Li, Yang
    Liu, Wei
    Gao, Xinliang
    Zhang, Kewei
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 639 - 644
  • [26] SURVIVIN SPLICED VARIANTS AND CELL VIABILITY OF NON SMALL CELL LUNG CANCER
    Hoshi, Fumihiko
    Endo, Chiaki
    Sakurada, Akira
    Notsuda, Hirotsugu
    Okada, Yoshinori
    Watanabe, Yui
    Eba, Shunsuke
    Watanabe, Tatsuaki
    Kawamura, Masaki
    Saito, Yasuki
    Hasumi, Toru
    Kondo, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S759 - S759
  • [27] Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer
    Yu, Hong
    Jiang, Lin
    Sun, Canlin
    Guo, Lingchuan
    Lin, Mei
    Huang, Junxing
    Zhu, Li
    GENE, 2014, 534 (01) : 60 - 65
  • [28] Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway
    Wang, Haini
    Zuo, Junli
    ANALYTICAL CELLULAR PATHOLOGY, 2021, 2021
  • [29] Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer
    Limacher, Jean-Marc
    Spring-Giusti, Clementine
    Bellon, Nadine
    Ancian, Philippe
    Rooke, Ronald
    Bonnefoy, Jean-Yves
    EXPERT REVIEW OF VACCINES, 2013, 12 (03) : 263 - 270
  • [30] Surgical treatment of non-small-cell lung cancer in octogenarians
    Guerra, Miguel
    Neves, Paulo
    Miranda, Jose
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2013, 16 (05) : 673 - 680
12345